SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,565,000 | +1433.3% | 250,000 | +594.4% | 2.35% | +642.6% |
| Q2 2017 | $1,863,000 | -17.7% | 36,000 | 0.0% | 0.32% | -28.3% |
| Q1 2017 | $2,263,000 | -28.0% | 36,000 | -48.6% | 0.44% | -3.9% |
| Q4 2015 | $3,142,000 | +63.0% | 70,000 | +40.0% | 0.46% | +87.0% |
| Q3 2015 | $1,928,000 | -71.5% | 50,000 | -64.3% | 0.25% | -63.0% |
| Q2 2015 | $6,776,000 | -4.2% | 140,000 | -30.0% | 0.66% | -9.8% |
| Q1 2015 | $7,070,000 | +22.4% | 200,000 | +28.7% | 0.74% | +3.1% |
| Q3 2014 | $5,776,000 | -49.3% | 155,360 | -47.8% | 0.71% | -74.6% |
| Q2 2014 | $11,391,000 | +95.6% | 297,800 | +133.0% | 2.81% | +111.2% |
| Q1 2014 | $5,823,000 | +18.9% | 127,800 | +4.1% | 1.33% | -2.6% |
| Q4 2013 | $4,898,000 | – | 122,800 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |